Changes in LASSI-L performance over time among older adults with amnestic MCI and amyloid positivity: A preliminary study

J Psychiatr Res. 2021 Nov:143:98-105. doi: 10.1016/j.jpsychires.2021.08.033. Epub 2021 Aug 26.

Abstract

There is a pressing need to develop measures that are sensitive to the earliest subtle cognitive changes of Alzheimer's disease (AD) to improve early detection and track disease progression. The Loewenstein-Acevedo Scales of Semantic Interference (LASSI-L) has been shown to successfully discriminate between cognitively unimpaired (CU) older adults and those with amnestic mild cognitive impairment (MCI) and to correlate with total and regional brain amyloid load. The present study investigated how the LASSI-L scores change over time among three distinct diagnostic groups. Eighty-six community-dwelling older adults underwent a baseline evaluation including: a clinical interview, a neuropsychological evaluation, Magnetic Resonance Imaging (MRI), and amyloid Positron Emission Tomography (PET). A follow up evaluation was conducted 12 months later. Initial mean values were calculated using one-way ANOVAs and chi-square analyses. Post-hoc comparisons were conducted using Tukey's Honestly Significant Difference (HSD). A 3 × 2 repeated measures analysis was utilized to examine differences in LASSI-L performance over time. The MCI amyloid positive group demonstrated a significantly greater decline in LASSI-L performance than the MCI amyloid negative and CU groups respectively. The scales that best differentiated the three groups included the Cued A2, which taps into maximum learning capacity, and Cued B2, which assesses the failure to recover from proactive semantic interference. Our findings further support the LASSI-L's discriminative validity.

Keywords: Alzheimer's disease; Biomarkers; Cognitive outcome measures; Dementia; Mild cognitive impairment; Proactive semantic interference.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Alzheimer Disease* / complications
  • Alzheimer Disease* / diagnostic imaging
  • Brain / diagnostic imaging
  • Cognitive Dysfunction* / diagnostic imaging
  • Humans
  • Magnetic Resonance Imaging
  • Neuropsychological Tests
  • Positron-Emission Tomography
  • Semantics